Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer (Q44567799)

From Wikidata
Jump to navigation Jump to search
scientific article published in September 2003
edit
Language Label Description Also known as
English
Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer
scientific article published in September 2003

    Statements

    Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit